Timothy D. Fensky, RPh, DPh, FACA, was elected to serve as the 2019-2020 president-elect of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 115th Annual Meeting, May 16-18, 2019, in Minneapolis, MN. Prior to the election, Mr Fensky served a one-year term as the NABP treasurer. He also served a two-year term as an Executive Committee member representing District 1.
Mr Fensky is a member of the Massachusetts Board of Registration in Pharmacy and previously served as president of the Board. He is also the current chair of the MassHealth Drug Utilization Review Board. He began his career as a community pharmacist at Sullivan’s Pharmacy and Medical Supply, where he later became pharmacy manager for institutional services. Currently, Mr Fensky is the pharmacy administrator at Bournewood Health Systems, where he oversees all pharmacy operations for psychiatric and substance use treatment services. In addition, Mr Fensky is the chief pharmacy officer at Sullivan’s Health Care, which he helped create to provide closed-door pharmacy services to long-term care facilities, assisted living facilities, group residences, hospices, and specialized schools.
As a member of NABP, Mr Fensky served on the Task Force on Best Practices for Veterinary Compounding and the Task Force on Pharmacist Prescriptive Authority. He also previously served as a moderator at several NABP Interactive Forums. In addition, Mr Fensky represents NABP on the Pharmacy Compounding Advisory Committee to Food and Drug Administration.
Mr Fensky is an active member of several other pharmacy organizations, including the Massachusetts Pharmacists Association, where he previously served as president-elect and vice president, and the Massachusetts Independent Pharmacists Association, where he served on the board as president. In addition, Mr Fensky is a member of the International Academy of Compounding Pharmacists, the National Community Pharmacists Association, and the American Society of Health-System Pharmacists. He currently serves on the MassHealth Drug Utilization Review Advisory Board and previously served on the Massachusetts Department of Mental Health Medication Administration Program Advisory Committee for two years. Mr Fensky is recognized as a full fellow for the American College of Apothecaries.
Providing his insights on sterile compounding, Mr Fensky has delivered several presentations on United States Pharmacopeia compounding standards and regulatory updates for the Massachusetts Pharmacists Association and Northeastern University. He is an adjunct faculty member at both the Massachusetts College of Pharmacy and Health Sciences (MCPHS) and Northeastern University, Bouvé College of Pharmacy and Health Sciences. Mr Fensky is also recognized as a preceptor to the MCPHS Advanced Pharmacy Experience Program and for the Cardinal Health/Sullivan’s Pharmacy/MCPHS University Specialized Residency Program.
Mr Fensky earned his bachelor of science degree in pharmacy from Northeastern University, Bouvé College of Pharmacy and Health Sciences, and received an honorary doctor of pharmacy license from the Oklahoma State Board of Pharmacy.
NABP is the independent, international, and impartial Association that assists its state member boards and jurisdictions for the purpose of protecting the public health.